Alkatout et al. revealed a number of protein differentially expressed between benign and malignant tumors, for example, expression of GSN and TPD52 proteins was upregulated in benign insulinomas, both by 3.9 fold27. This evidence concerns the gene GSN and pancreatic insulinoma.